Evaluating a new type of CT imaging technology
Clinical Feasibility and Evaluation of Silicon Photon Counting CT
This study is testing a new type of CT scan technology to see if it can provide clearer images while using less radiation for patients needing scans.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | GE Healthcare Industry-sponsored |
| Drugs / interventions | radiation |
| Locations | 1 site (Palo Alto, California) |
| Trial ID | NCT05838482 on ClinicalTrials.gov |
What this trial studies
This study aims to collect data on the clinical utility of photon-counting CT technology. It will assess various image quality parameters such as spatial resolution, image contrast, and noise, with the goal of demonstrating how this technology can reduce radiation exposure during CT imaging. The findings will support regulatory submissions and enhance clinical applications of CT technology. Participants will undergo clinically-indicated CT exams, and their imaging data will be analyzed for quality assessment.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who are scheduled for a clinically-indicated CT exam within a specified timeframe.
Not a fit: Patients who are pregnant, have allergies to contrast agents, or require urgent care may not benefit from this study.
Why it matters
Potential benefit: If successful, this technology could lead to safer CT imaging with reduced radiation doses for patients.
How similar studies have performed: Other studies have shown promise in improving CT imaging technology, but this specific approach is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Who are 18 years of age or older * Able to sign and date the informed consent form * Who have in the past 120 days or will in the future 30 days undergo a clinically-indicated CT exam of the head, neck, heart, chest, abdomen, pelvis, or extremities where images are available for this prior scheduled exam Exclusion Criteria: * Who are pregnant or lactating; * Who were previously enrolled in this study; * For contrast-enhanced CT exams, anyone with known or suspected allergy to iodinated contrast agents * For contrast-enhanced CT exams, anyone with known or suspected renal insufficiency as determined by site medical personnel; * Who need urgent or emergent care; * Who have any conditions that, in the opinion of the PI or designee, would interfere with the evaluation of the results or constitute a health hazard for the subject; OR * Who are unwilling to have GEHC personnel present for the CT exam.
Where this trial is running
Palo Alto, California
- Stanford University — Palo Alto, California, United States (Recruiting)
Study contacts
- Study coordinator: Melissa Challman
- Email: melissa.challman@gehealthcare.com
- Phone: +1-858-221-3007
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.